C1498 In Vitro Boyden Chamber Assay (Angiogenesis)
CAT#: ITS-1122-YF4674
Target Cell Organism: Mouse
Target Cell Name: C1498
Assay Type: Angiogenesis Monitoring Assays
Assay Overview
This assay is to provide C1498-based In Vitro Boyden Chamber Assay (Angiogenesis) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
C1498
Target Cell Organism
Mouse
Target Cell Background
C1498 is a murine myeloid leukemia cell line isolated from a C57BL/6J mouse. It most closely resembles acute myeloid leukemia (AML), and is highly lethal when implanted into syngeneic mice.
Related Diseases
Acute Myeloid Leukemia; AML
Research Area
Oncology
Assay Name
In Vitro Boyden Chamber Assay (Angiogenesis)
Short Description
C1498-cell based In Vitro Boyden Chamber Assay (Angiogenesis)
Assay Description
The Boyden chamber assay has been used to study angiogenesis by assessing endothelial cell migration.
Assay Type
Angiogenesis Monitoring Assays
Assay Type Details
Local and regional metastasis is a life-threatening condition in cancer, which is hard to control with the available cancer treatment options. In metastasis, cancer cells move away from primary tumors and travel through the blood and lymphatic system and form new tumors on other parts. A vascular network growth is important for cancer metastasis. Angiogenesis is a process that is known as the formation of new blood vessels with the help of existing blood vessels and angiogenesis has been reported to play a major role in cancer growth and metastasis. Tumors can send chemical signals to nearby normal tissues to stimulate angiogenesis. New blood vessels can feed growing tumors with nutrients and oxygen, allowing cancer cells to spread (metastasis).